 | Up a level |
Schlange, Carling; Müller, Joachim; Imhof, Dennis; Hänggeli, Kai Pascal Alexander; Boubaker, Ghalia; Ortega-Mora, Luis-Miguel; Wong, Ho Ning; Haynes, Richard K; Van Voorhis, Wesley C; Hemphill, Andrew (2023). Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice. Experimental parasitology, 255(108655), p. 108655. Elsevier 10.1016/j.exppara.2023.108655
Müller, Joachim; Schlange, Carling; Heller, Manfred; Uldry, Anne-Christine; Braga-Lagache, Sophie; Haynes, Richard K; Hemphill, Andrew (2023). Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation. International journal for parasitology. Drugs and drug resistance, 21, pp. 1-12. Elsevier 10.1016/j.ijpddr.2022.11.005
Imhof, Dennis; Pownall, William Robert; Schlange, Carling; Monney, Camille; Ortega-Mora, Luis-Miguel; Ojo, Kayode K; Van Voorhis, Wesley C; Oevermann, Anna; Hemphill, Andrew (2022). Vaccine-Linked Chemotherapy Approach: Additive Effects of Combining the Listeria monocytogenes-Based Vaccine Lm3Dx_NcSAG1 With the Bumped Kinase Inhibitor BKI-1748 Against Neospora caninum Infection in Mice. Frontiers in veterinary science, 9, p. 901056. Frontiers Media 10.3389/fvets.2022.901056
